Ledger.Open graph →
SEC Form D · filed August 23, 2024

Pelage Pharmaceuticals, Inc

Offering
$14.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

William E. Lowry · Los Angeles, CADirectorHeather E. Christofk · Los Angeles, CAExecDaniel Gil · Los Angeles, CAExec · DirectorCathy E. Friedman · Los Angeles, CADirectorIsaac D. Barchas · Austin, TXDirectorJim B. Graham · Austin, TXExec · DirectorSara Lewis · Brooklyn, NYDirectorBryan Bedard · La Jolla, CAExecRoger A. Le Tissier · St Peter Port, Y7Exec · DirectorPeter Sheppeard · Toronto, Ontario, CanadaDirectorJohn C. Loveless · St Peter Port, Y7ExecJeremy J. Coller · St Peter Port, Y7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗